Comparing the five groups according to the serum ALT level, the prevalence of newly developed COPD was 2.8%, 3.3%, 3.8%, 3.7%, and 3.1%, respectively (P < 0.0001; Fig. 1A). Here, GPT is linked to chronic obstructive pulmonary disease.